Four For Friday | March 20, 2026
LF212 Biodiversity loss is a security threat, the $10 trillion nature opportunity, dog reinvents cancer research, stem cells reduce frailty + AI product factory
Welcome to this week’s Four For Friday, from Chamonix, in the French Alps, where I’m reconnecting with Europe at a fascinating time. Lots of conversations about global security, the impact of AI and aging populations. For this week, a brace of stories on the environment and a couple on inspiring health and longevity innovations - enjoy!
1. Biodiversity loss: a national security threat
The UK government has published an alarming intelligence-style assessment: ecosystem collapse is now a tier-one national security risk.
The numbers are eyebrow-raising: monitored wildlife populations declined 73% between 1970 and 2020, freshwater species fell 84%, and six of nine planetary boundaries have already been crossed.
The Amazon, currently at 17% deforestation, is estimated to collapse at 20-25% when combined with temperature rises and forest fires — an uncomfortably thin margin. Coral reefs in Southeast Asia and boreal forests could start collapsing from 2030; rainforests and mangroves from 2050. Downstream consequences run from crop failures and pandemic risk through to interstate conflict over arable land. The total annual value of ecosystem services to the UK alone was £87 billion in 2022 (3% of GDP).
The So What? Ecosystem collapse reframes nature loss as geopolitical risk, demanding security-grade planning responses.
2. The $10 trillion nature economy
The World Economic Forum has published a new report identifying 50 investible opportunities in the nature-positive economy — a market the report values at $10 trillion annually by 2030. The green economy (largely energy transition) already represents $8 trillion in listed equity and has outperformed global equities by 59% since 2008.
The 50 opportunities span 13 sectors — from precision farming and alternative proteins to circular chemicals and data centre water management — and are categorised by readiness: some can be financed through conventional lending today; others need venture capital or blended finance to reach commercial scale.
The So What? Investing in nature makes good financial sense; this report helps answer the question of how to actually do it.
3. This dog may change cancer medicine
Sydney tech exec Paul Conyngham may have changed the face of cancer.
When his rescue dog Rosie was given one to six months to live after a cancer diagnosis, he fed her genomic data into ChatGPT and AlphaFold, identified tumour neoantigens, and designed a personalised mRNA vaccine for $3,000.
UNSW’s RNA Institute manufactured the bespoke vaccine in under two months. The tennis-ball-sized tumour on Rosie’s leg had shrunk by roughly 75% by mid-March. Moderna and Merck are spending billions on the same mRNA approach for humans, with Phase 3 trials underway. The pipeline — sequence the tumour, model the mutations, design a targeted mRNA vaccine — can now be compressed from years into months using freely available AI tools.
The So What? AI just democratised personalised cancer vaccine design; the bottleneck is now regulatory, not scientific.
4. Stem cells reduce frailty in older adults
Frailty afflicts a substantial share of older adults and has had no effective therapy. A new study showed that mesenchymal stem cells (MSCs) from young adult donors showed dose-dependent improvements in the 6-minute walk test six months post-injection, with higher doses producing greater gains.
The researchers also identified a new biomarker: sTIE2, a protein associated with vascular inflammation, was significantly reduced.
Prior studies show MSCs (approved by the FDA in 2024) also increase brain volume and enhance cognition in Alzheimer’s patients, suggesting a broader anti-ageing platform.
The So What? Long limited to race horses and athletes, stem cell therapy moving from fringe to clinical reality, with frailty as a potential first breakout sector.
AI Lesson of the Week: AI Product Factory
Practical video for those interested in using AI tools to make money. Learn from this guy who creates and launches a new business every month in his AI venture studio. (Thanks @Michael for the tip!)
That’s all for now - happy weekend everyone.
- Stephen